Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.

Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells. Nat Commun (2015) 1.43

Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer (2015) 0.92

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J (2015) 0.87

Hepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011). HPB Surg (2015) 0.78

Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma. Sci Rep (2017) 0.78

Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm. Oncologist (2016) 0.77

Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma. Pediatr Blood Cancer (2016) 0.76

Creating an effective clinical registry for rare diseases. United European Gastroenterol J (2015) 0.75

A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. Am J Case Rep (2017) 0.75

Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol (2016) 0.75

Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy. ACG Case Rep J (2016) 0.75

Synchronous Fibrolamellar Hepatocellular Carcinoma and Auricular Myxoma. Case Rep Pathol (2015) 0.75

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30

Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer (1980) 3.82

Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology (2004) 2.62

Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol (2005) 1.90

Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol (2002) 1.45

Hepatocellular carcinoma in young people. Cancer (1983) 1.36

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer (2010) 1.34

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol (1988) 1.30

Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17

Fibrolamellar hepatoma. Am J Surg (1985) 1.14

Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg (1988) 1.05

Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer (1983) 1.05

Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg (1986) 0.98

Primary cancer of the liver. Evaluation, treatment, and prognosis. Arch Surg (1989) 0.83